Bottom line
BGVIX vs AGVGX: the short answer
BGVIX (Brandes Global Equity Fund) and AGVGX (American Funds Global Insight Fund) are both mutual funds.
But AGVGX is far broader, holding 189 positions to 69 for BGVIX, so beyond the top names it adds exposure BGVIX doesn't have.
AGVGX is cheaper at 0.56% vs 0.9% — a difference of $34 a year per $10,000 invested.
Over five years, BGVIX returned +15.8% a year vs +7.9% for AGVGX (reporting dates differ).
Updated Nov 19, 2026
BGVIX vs AGVGX side by side
| BGVIX | AGVGX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Datum One | American Funds (Capital Group) |
| Category | Global Stock | Global Stock |
| Expense ratio | 0.9% | 0.56% |
| Annual cost per $10k | $90 | $56 |
| 10-yr cost on $10k (prospectus) | $1,290 | $701 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +33.5% | +10.4% |
| 5-yr return (annualized) | +15.8% | +7.9% |
| 10-yr return (annualized) | +10.9% | — |
| Best quarter | +22.7% | +17.3% |
| Worst quarter | −29.5% | −17.8% |
| Net assets (fund) | $82.2M | $21.5B |
| Number of holdings | 69 | 189 |
| Portfolio turnover | 31% | 35% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
BGVIX and AGVGX share none of their top holdings.
BGVIX top 10
- Taiwan Semiconductor Manu — 2.88%
- Gsk Plc — 2.58%
- Sap Se — 2.49%
- Becton Dickinson & Co — 2.35%
- Sanofi Sa — 2.32%
- Erste Group Bank Ag — 2.27%
- Cigna Group/the — 2.27%
- Samsung Electronics Co N/ — 2.25%
- Textron Inc — 2.23%
- Ubs Group Ag Usd0.10 (reg — 2.15%
AGVGX top 10
- Broadcom Inc — 4.47%
- Taiwan Semiconductor Manufacturing Co Ltd — 3.55%
- Microsoft Corp — 3.53%
- Alphabet Inc — 3.15%
- Apple Inc — 3.07%
- Capital Group Central Cash Fund — 2.88%
- Asml Holding Nv — 2.52%
- Jpmorgan Chase & Co — 2.25%
- Sk Hynix Inc — 2.24%
- General Electric Co Aka Ge Aerospace — 2.10%
FAQ
What is the difference between BGVIX and AGVGX?
Which is cheaper, BGVIX or AGVGX?
Should I own both BGVIX and AGVGX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.